More about High-Yield Cash Accounts with M1
Brokerage Accounts
Retirement Accounts
Other Accounts
Quotes are delayed by 15 minutes.
1D
1W
1M
3M
6M
YTD
1Y
2Y
5Y
ALL
Market cap
$3.72B
EPS
0.58
P/E ratio
39.6
Price to sales
1.29
Dividend yield
--
Beta
0.888063
Previous close
$22.97
Today's open
$22.94
Day's range
$22.83 - $23.19
52 week range
$18.77 - $30.42
show more
CEO
Paul Keel
Employees
12000
Headquarters
Brea, CA
Exchange
New York Stock Exchange
Shares outstanding
160617709
Issue type
Common Stock
Healthcare
Medical Equipment & Supplies
Envista (NVST) is a Top-Ranked Value Stock: Should You Buy?
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Zacks Investment Research • Oct 9, 2026

Here's Why Envista (NVST) is a Strong Growth Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Zacks Investment Research • Oct 8, 2026

Envista Schedules Third Quarter 2026 Earnings Call
BREA, Calif., Oct. 6, 2026 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) ("Envista") will report financial results for its third quarter 2026 on Wednesday, November 4, 2026.
PRNewsWire • Oct 6, 2026

New Strong Buy Stocks for September 28th
VG, HCSG, NVST, EQNR and HMN have been added to the Zacks Rank #1 (Strong Buy) List on September 28, 2026.
Zacks Investment Research • Sep 28, 2026

NVST vs. ABT: Which Stock Is the Better Value Option?
Investors with an interest in Medical - Products stocks have likely encountered both Envista (NVST) and Abbott (ABT). But which of these two companies is the best option for those looking for undervalued stocks?
Zacks Investment Research • Sep 25, 2026

Best Value Stocks to Buy for September 21st
SLDE, HHH and NVST made it to the Zacks Rank #1 (Strong Buy) value stocks list on September 21st, 2026.
Zacks Investment Research • Sep 21, 2026

Down 12% in 4 Weeks, Here's Why You Should You Buy the Dip in Envista (NVST)
Envista (NVST) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
Zacks Investment Research • Sep 18, 2026

Should Value Investors Buy Envista (NVST) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Zacks Investment Research • Sep 18, 2026

Envista Holdings Corporation (NVST) Analyst/Investor Day Transcript
Envista Holdings Corporation (NVST) Analyst/Investor Day Transcript
Seeking Alpha • Sep 18, 2026

Here's Why Envista (NVST) is a Strong Value Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Zacks Investment Research • Sep 17, 2026

¹ Disclosures

Open an M1 investment account to buy and sell Envista Holdings Corporation commission-free¹. Build wealth for the long term using automated trading and transfers.